tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amgen Earnings Call: Broad Growth Amid Manageable Risks
PremiumCompany AnnouncementsAmgen Earnings Call: Broad Growth Amid Manageable Risks
12d ago
Amgen’s FORTITUDE-301 Cancer Trial Completion: What Investors Should Watch in Bemarituzumab’s Next Act
Premium
Company Announcements
Amgen’s FORTITUDE-301 Cancer Trial Completion: What Investors Should Watch in Bemarituzumab’s Next Act
12d ago
Amgen price target raised to $360 from $335 at RBC Capital
Premium
The Fly
Amgen price target raised to $360 from $335 at RBC Capital
12d ago
Closing Bell Movers: AMD down 8% on earnings despite beat
PremiumThe FlyClosing Bell Movers: AMD down 8% on earnings despite beat
13d ago
Amgen reports Q4 adjusted EPS $5.29, consensus $4.76
Premium
The Fly
Amgen reports Q4 adjusted EPS $5.29, consensus $4.76
13d ago
Amgen sees FY26 adjusted EPS $21.60-$23.00, consensus $22.14
Premium
The Fly
Amgen sees FY26 adjusted EPS $21.60-$23.00, consensus $22.14
13d ago
The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, Feb. 1
16d ago
AMGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AMGN Earnings this Week: How Will it Perform?
16d ago
Amgen Ends Kyowa Kirin Collaboration in Strategic Shift
Premium
Company Announcements
Amgen Ends Kyowa Kirin Collaboration in Strategic Shift
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100